Publication for CD2 and CCR2
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | CD2 | CD2 molecule | 914 | [link] | ||
| hsa | CCR2 | C-C motif chemokine receptor 2 | 729230 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 31451770 | 0.85 | T11 is enriched with immunosuppressive TIMs (Fig. 5b), and CCR2 KO improved ICB responses: 5/5 T11 tumors regressed completely (Fig. 7b). |
| 0.65 | CCR2 KO hosts bearing T11 and 2208L tumors as representatives of MES and NES, respectively. | |
| 31484464 | 0.83 | CD2/CCR2b engineered CAR T cells and mesothelin CAR/CCR2 T cells showed a migration and homing increase of the CAR T ranging bethween 10- and 12-fold into neuroblastoma tumors and malignant pleural mesothelioma, respectively. |
| 27677639 | 0.82 | CCR2, and CCL5); and T cells (CD96, CD3D and CD2) (Supplemental Fig. 4, clusters 2-4). |
| 31511014 | 0.52 | CCR2, CX3CR1, CXCL2, etc.), CD molecules (CD2, CD4, CD22, etc.), tumor necrosis factor receptor superfamily (TNFRSF10C, TNFSF8, etc.), cadherin related members (CDH8, CDHR1, CDHR4, etc.) and so on. |
The preparation time of this page was 0.0 [sec].
